GlassScriptPhysician profile
Brian J Welch
NPI 1386694966
$10,755.07
in general payments reported to CMS, 2019-2025
61 companies · $2,098 in 2025
The $2,098 reported for 2025 was more than what 77% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,168 · 2020: $338 · 2021: $72.88 · 2022: $1,273 · 2023: $2,505 · 2024: $2,300 · 2025: $2,098.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,726 · Education: $176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,725.85 |
| Education | $176.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,341.44 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,005.87 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Mannkind Corporation | $784.37 | 2019-2025 | Afrezza |
| Insulet Corporation | $556.35 | 2019-2025 | Omnipod |
| Amgen INC. | $516.21 | 2019-2025 | Tepezza, Evenity, Repatha |
| Abbott Laboratories | $505.95 | 2019-2025 | Freestyle Libre 3 |
| Ibsa Pharma INC. | $457.57 | 2019-2025 | Licart, Tirosint, Flector |
| Embecta Corp. | $455.83 | 2023-2024 | Bd Nano 2nd Gen Pen Needle |
| Amneal Pharmaceuticals LLC | $340.21 | 2019-2025 | Unithroid |
| Antares Pharma, INC. | $334.58 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Xeris Pharmaceuticals, INC. | $308.67 | 2023-2025 | Gvoke Hypopen |
| Corcept Therapeutics | $290.99 | 2019-2025 | Korlym |
| Dexcom, INC. | $280.51 | 2019-2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $268.41 | 2019-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $226.54 | 2019-2025 |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $171.70 | 2019-2024 | Synthroid, Botox |
| Medtronic, INC. | $168.17 | 2022-2025 | Minimed 780g |
| Recordati_rare_diseases_inc. | $142.66 | 2022-2025 | Isturisa, Signifor Lar |
| Pfizer INC. | $141.45 | 2019-2024 | |
| Vifor Pharma, INC. | $133.19 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $132.51 | 2019-2022 | |
| Amarin Pharma, INC. | $129.13 | 2019-2021 | |
| Beta Bionics, INC. | $125.42 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Ipsen Biopharmaceuticals, INC | $123.61 | 2019-2022 | |
| Currax Pharmaceuticals LLC | $118.82 | 2023 | Nexletol, Nexlizet, Contrave |
| Radius Health, INC. | $117.16 | 2019-2023 | Tymlos |
| Neurocrine Biosciences, INC. | $107.03 | 2024-2025 | |
| Halozyme INC | $101.01 | 2023 | |
| Alexion Pharmaceuticals, INC. | $91.04 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $89.46 | 2019-2023 | Cycloset |
| Tolmar, INC. | $88.67 | 2023-2025 | Jatenzo |
| Cequr Corporation | $87.96 | 2022-2024 | Cequr Simplicity |
| Bayer Healthcare Pharmaceuticals INC. | $73.20 | 2023-2025 | |
| Tandem Diabetes Care, INC. | $73.07 | 2019-2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Becton, Dickinson and Company | $67.23 | 2019-2022 | |
| Shire North American Group INC | $63.79 | 2019 | |
| Avvisto Therapeutics, LLC | $59.28 | 2024-2025 | Cycloset |
| Ascendis Pharma Endocrinology INC | $52.89 | 2025 | Yorvipath |
| Alvogen INC | $52.40 | 2023-2025 | Teriparatide |
| Soleno Therapeutics, INC. | $47.14 | 2025 | Vykat Xr |
| Regeneron Healthcare Solutions, INC. | $41.48 | 2019 | |
| Sequel Med Tech, LLC | $40.31 | 2025 | Twiist |
| Acella Pharmaceuticals, LLC | $39.53 | 2024-2025 | NP Thyroid 60 |
| Merck Sharp & Dohme LLC | $35.26 | 2019-2020 | |
| Ascensia Diabetes Care US INC. | $33.10 | 2025 | |
| Verity Pharmaceuticals INC. | $32.12 | 2024-2025 | Tlando |
| Amryt Pharma Holdings LTD | $31.17 | 2022-2023 | Mycapssa |
| Medtronic Minimed, INC. | $30.77 | 2019 | |
| Eisai INC. | $29.45 | 2019 | |
| Companion Medical, INC. | $28.77 | 2019 | |
| Eusa Pharma (US) LLC | $19.92 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $19.80 | 2022 | |
| Janssen Pharmaceuticals, INC | $19.51 | 2019 | |
| Gilead Sciences, INC. | $18.16 | 2019 | |
| Chiesi USA, INC. | $18.01 | 2025 | Mycapssa |
| Zealand Pharma US, INC. | $16.78 | 2022 | |
| Kyowa Kirin, INC. | $16.39 | 2023 | Crysvita |
| Acerus Pharmaceuticals Corporation | $15.18 | 2022 | |
| Horizon Therapeutics Plc | $12.90 | 2023 | Tepezza |
| Acessa Health INC. | $12.63 | 2019 | |
| Aytu Biopharma, INC. | $12.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Welch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.